The 29th Annual Meeting of the Japanese Society for Vaccinology/The 66th Annual Meeting of the Japanese Society of Clinical Virology
Advanced Search

Session Details

Oral DiscussionClinical Vaccinology

Oral Presentation 3 : Clinical vaccinology

Sat. Sep 27, 2025 10:55 AM - 11:45 AM JST
Sat. Sep 27, 2025 1:55 AM - 2:45 AM UTC
Room 4(2F Small Hall)
Chair:Takuo Mizukami, Satoshi Hirakawa
10:55 AM - 11:05 AM JST(1:55 AM - 2:05 AM UTC)

[O3-01]JN.1型mRNAワクチン及び組換えタンパクワクチンブースター接種によるSARS-CoV-2オミクロン変異株に対する免疫原性の評価

*Yohei Seki1, Kiyoko Nojima1, Sayuri Sakuragi 1, Haruka Momose1, Wakako Kuribayashi1, Kei Miyakawa2, Shutoku Matsuyama3, Hideki Hasegawa2, Yasuo Yoshihara4, Takuo Mizukami1 (1. Center for Next-Generation Biologics Research, National Institute of Infectious Diseases, Japan Institute for Health Security, 2. Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, 3. Department of Respiratory Viruses, National Institute of Infectious Diseases, Japan Institute for Health Security, 4. National Hospital Organization Murayama Medical Center)
11:05 AM - 11:15 AM JST(2:05 AM - 2:15 AM UTC)

[O3-02]Blood dynamics of mRNA vaccines in individuals who received multiple doses of SARS-CoV-2 mRNA vaccine (Pfizer Inc., Comirnaty intramuscular injection)

*Takuo Mizukami1, Sayuri Sakuragi1, Kiyoko Nojima1, Wakako Kuribayashi1, Mami Uemura1, Emi Ikebe1, Ryo Amano1, Kenta Tezuka1, Kou Hiraga1, Yasuo Yoshihara2, Yohei Seki1 (1. Center for Next-Generation Biologics Research, National Institute of Infectious Diseases, Japan Institute for Health Security, 2. Murayama Medical Center, National Health Organization)
11:15 AM - 11:25 AM JST(2:15 AM - 2:25 AM UTC)

[O3-03]閉鎖病棟における新型コロナウイルス感染症集団感染事例で4年後に同一集団内で発生した2回目の集団感染

*Hajime Kusuhara1, Shinji Nakase2, Shinichi Kanehara2, Hitoshi Hirano2, Tomoyuki Uno3, Yasuyuki Hara3, kiyosu Taniguchi4, Katsuhiro Komase5, Hajime Kamiya6 (1. Mie Prefecture Health and Environment Research Institute, 2. Suzuka Kosei Hospital, 3. Department of Medical Health, Mie Prefecture, 4. NHO Mie National Hospital, 5. Japan Institute for Health Security, National Institute of Infectious Diseases, Department of Infectious Disease Surveillance, 6. Department of Public Health, Occupational Medicine, and Applied Epidemiology, Mie University Graduate School of Medicine)
11:25 AM - 11:35 AM JST(2:25 AM - 2:35 AM UTC)

[O3-04]SARS-COV2mRNA脂質ナノ粒子製剤接種後症候群（PVS）の実態と臨床的特徴
〜全国14施設レジストリによる多症状・長期化の検討〜

*Akinori Fujisawa1, Shinichiro Kodama2, Nafuko Konishi3, Jun Ueda4, Eiji Nakatani5, Masanori Fukushima6 (1. Kokoro Medical Corporation, Honbetsu Cardiovascular Medicine Clinic, 2. Kodama Hospital & Kodama Medical Office, 3. Viola Clinic, 4. Department of Advanced Medical Science, Asahikawa Medical University, 5. Department of Biostatistics and Health Data Science, Graduate School of Medical Science Nagoya City University, 6. Learning Health Society Institute)
11:35 AM - 11:45 AM JST(2:35 AM - 2:45 AM UTC)

[O3-05]小児における新型コロナワクチン接種後の有害事象発生頻度およびリスク因子の解明

*Hisao Okabe1, Koichi Hashimoto1, Kenta Kuwana1, Masato Hoshino1, Mamiko Nakazawa1, Yohei Kume1, Yuichiro Asano1, Mina Chishiki1, Masahiro Watanabe1, Masatoki Sato1, Mitsuaki Hosoya1, Hayato Go1 (1. Department of Pediatrics, School of Medicine, Fukushima Medical University)
Back to Category List